GSK

Latest stories

18h
Northern Echo
"Lightbulb" moment over mouthwash ingredient will help North-East drug plant save thousands of babies' liveswas Dr Pauline Williams, who saw potential for the drug while reading a United
"Lightbulb" moment over mouthwash ingredient will help North-East drug plant save thousands of babies' lives
Northern Echo / Posted 18 hours ago
was Dr Pauline Williams, who saw potential for the drug while reading a United Nations report at home. Dr Williams, GSK’s head of global health research and development, says the document pinpointed the antiseptic chlorhexidine as a possible... Read more
3 related stories
19h
Northern Echo
"Lightbulb" moment over mouthwash ingredient which will help North-East drug plant save thousands of babies' liveswas Dr Pauline Williams, who saw potential for the drug while reading a United
"Lightbulb" moment over mouthwash ingredient which will help North-East drug plant save thousands of babies' lives
Northern Echo / Posted 19 hours ago
was Dr Pauline Williams, who saw potential for the drug while reading a United Nations report at home. Dr Williams, GSK’s head of global health research and development, says the document pinpointed the antiseptic chlorhexidine as a possible... Read more
3 related stories
1d
International Business Times
GlaxoSmithKline gel developed from a mouthwash could save thousands of babies GlaxoSmithKline (GSK) has reformulated its Corsodyl mouthwash to develop an ant
GlaxoSmithKline gel developed from a mouthwash could save thousands of babies
International Business Times / Posted yesterday
GlaxoSmithKline (GSK) has reformulated its Corsodyl mouthwash to develop an antiseptic gel. This gel has the ability to prevent umbilical cord infections in newborn babies and could hence save thousands of baby lives. The gel, which is called... Read more
3 related stories
1d
Northern Echo
"Lightbulb" moment will help North-East drug plant saving thousands of babies' liveswas Dr Pauline Williams, who saw potential for the drug while reading a United
"Lightbulb" moment will help North-East drug plant saving thousands of babies' lives
Northern Echo / Posted yesterday
was Dr Pauline Williams, who saw potential for the drug while reading a United Nations report at home. Dr Williams, GSK’s head of global health research and development, says the document pinpointed the antiseptic chlorhexidine as a possible... Read more
1d
The Courier Mail
Drug study hid teen suicide risksaid the company had divested ownership of the medicine to drug company Aspen i
Drug study hid teen suicide risk
The Courier Mail / Posted yesterday
said the company had divested ownership of the medicine to drug company Aspen in 2012 and no longer made it. GSK had for a number of years been promoting data transparency to allow independent researchers to review drug company funded... Read more
1d
Channel NewsAsia
Reformulated GSK mouthwash endorsed as umbilical cord antisepticbe sold at a not-for-profit price. But the green light from the European Medic
Reformulated GSK mouthwash endorsed as umbilical cord antiseptic
Channel NewsAsia / Posted yesterday
be sold at a not-for-profit price. But the green light from the European Medicines Agency (EMA) is a timely victory for GSK as it battles critics who argue there are no benefits from combining pharmaceuticals with consumer healthcare products,... Read more
3 related stories
2d
North-West Evening Mail
Furness Rovers shoot for cup doublethe holders, while Rovers were runners-up in 2011. The Senior Cup final on Thu
Furness Rovers shoot for cup double
North-West Evening Mail / Posted 2 days ago
the holders, while Rovers were runners-up in 2011. The Senior Cup final on Thursday pits two West Lancashire League sides, GSK Ulverston Rangers, from Division One, and Furness Rovers, from Division Two, against each other. Rovers thrashed fellow... Read more
2d
The Economic Times
Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issuesand most have lost fancy of the Street, few stocks have found favour with the i
Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issues
The Economic Times / Posted 2 days ago
and most have lost fancy of the Street, few stocks have found favour with the investors. Biocon, Piramal Enterprises and GSK Pharma have emerged as top three gainers in the BSE Healthcare index in the past six months. Absence of FDA issues,... Read more
3d
The Economic Times
High-Flying PE-rich stocks may not be worth your timeany story about growth with little regard for sober investing. Shares of Jubila
High-Flying PE-rich stocks may not be worth your time
The Economic Times / Posted 3 days ago
any story about growth with little regard for sober investing. Shares of Jubilant FoodWorks, Bosch, Honeywell Automation, GSK Pharma and others have risen up to 26% in past two months. These stocks already command a price-to-earnings multiple of... Read more
3d
The Economic Times
Five themes that can give handsome returnsstarts going south these companies hit the hardest which are either leverage or
Five themes that can give handsome returns
The Economic Times / Posted 3 days ago
starts going south these companies hit the hardest which are either leverage or have high capital needs. MONSOON THEME: GSK Consumer, Hero Moto, M&M Financial, Rallis Monsoon is crucial for lifting rural demand which will aide revival of the... Read more
3d
heraldscotland
GlaxoSmithKline bolsters profits by nearly one-fifthwas boosted by the sale of its oncology business to Novartis Maxim Jacobs, ana
GlaxoSmithKline bolsters profits by nearly one-fifth
heraldscotland / Posted 3 days ago
was boosted by the sale of its oncology business to Novartis Maxim Jacobs, analyst at Edison Investment Research, said: "GSK reported surprisingly strong results on both the top and bottom line, driven mainly by strong vaccine sales as well as... Read more
3d
TheStreet.com
GlaxoSmithKline Shares Boosted by Strong First-Quarter Updatefrom the larger pharmaceuticals segment. The boost from new products has parti
GlaxoSmithKline Shares Boosted by Strong First-Quarter Update
TheStreet.com / Posted 3 days ago
from the larger pharmaceuticals segment. The boost from new products has particular significance to shareholders of GSK given the extent to which the group is reliant upon revenues from asthma treatment Advair, also known as Seretide, its... Read more
3d
Channel NewsAsia
GlaxoSmithKline rebound gathering pace, says outgoing CEOthe end of 2016. Both internal and external candidates are being considered and
GlaxoSmithKline rebound gathering pace, says outgoing CEO
Channel NewsAsia / Posted 3 days ago
the end of 2016. Both internal and external candidates are being considered and the choice of new CEO is seen signaling GSK's future direction. Witty has been under pressure over the last three years as profits have flagged and some investors... Read more
6 related stories
3d
Channel NewsAsia
Higher margins and new drugs help GlaxoSmithKline beat forecastshis focus on consumer health products, which range from headache pills to tooth
Higher margins and new drugs help GlaxoSmithKline beat forecasts
Channel NewsAsia / Posted 3 days ago
his focus on consumer health products, which range from headache pills to toothpaste, leading to calls for a break-up of GSK. Wednesday's results suggest the group is delivering on a pledge to boost profitability in its non-prescription... Read more
6 related stories
3d
The News & Observer
GSK sees rise in sales of vaccines, healthcare products | News & Observer April 27, 2016 8:32 AM British pharmaceutical company Gl
GSK sees rise in sales of vaccines, healthcare products
The News & Observer / Posted 3 days ago
| News & Observer April 27, 2016 8:32 AM British pharmaceutical company GlaxoSmithKline says earnings from its core business rose 19... Read more
5 related stories
3d
Your Hometown Lima Stations
GSK sees rise in sales of vaccines, healthcare productspounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by com
GSK sees rise in sales of vaccines, healthcare products
Your Hometown Lima Stations / Posted 3 days ago
pounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by competition for the Advair asthma treatment. GSK is struggling to develop blockbuster drugs as older treatments lose patent protection. CEO Andrew Witty says the results... Read more
5 related stories
3d
Salon.com
GSK sees rise in sales of vaccines, healthcare productspounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by com
GSK sees rise in sales of vaccines, healthcare products
Salon.com / Posted 3 days ago
pounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by competition for the Advair asthma treatment. GSK is struggling to develop blockbuster drugs as older treatments lose patent protection. CEO Andrew Witty says the results... Read more
5 related stories
3d
Island Packet
GSK sees rise in sales of vaccines, healthcare productspounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by com
GSK sees rise in sales of vaccines, healthcare products
Island Packet / Posted 3 days ago
pounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by competition for the Advair asthma treatment. GSK is struggling to develop blockbuster drugs as older treatments lose patent protection. CEO Andrew Witty says the results... Read more
5 related stories
3d
Daily Herald
GSK sees rise in sales of vaccines, healthcare productspounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by com
GSK sees rise in sales of vaccines, healthcare products
Daily Herald / Posted 3 days ago
pounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by competition for the Advair asthma treatment. GSK is struggling to develop blockbuster drugs as older treatments lose patent protection. CEO Andrew Witty says the results... Read more
5 related stories
3d
ABC News
GSK Sees Rise in Sales of Vaccines, Healthcare Productspounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by com
GSK Sees Rise in Sales of Vaccines, Healthcare Products
ABC News / Posted 3 days ago
pounds. Pharmaceutical sales fell 1 percent to 3.59 billion pounds, hurt by competition for the Advair asthma treatment. GSK is struggling to develop blockbuster drugs as older treatments lose patent protection. CEO Andrew Witty says the results... Read more
5 related stories
3d
Herald Sun
Better margins new drugs keep GSK on trackhad forecast sales of STG6.01 billion and core EPS, which excludes certain item
Better margins new drugs keep GSK on track
Herald Sun / Posted 3 days ago
had forecast sales of STG6.01 billion and core EPS, which excludes certain items, of 17.9p, according to Thomson Reuters. GSK said it expected 10 to 12 percentage growth in 2016 core EPS at constant currencies and confirmed that the dividend, one... Read more
6 related stories
3d
Weekly Times
Better margins new drugs keep GSK on trackhad forecast sales of STG6.01 billion and core EPS, which excludes certain item
Better margins new drugs keep GSK on track
Weekly Times / Posted 3 days ago
had forecast sales of STG6.01 billion and core EPS, which excludes certain items, of 17.9p, according to Thomson Reuters. GSK said it expected 10 to 12 percentage growth in 2016 core EPS at constant currencies and confirmed that the dividend, one... Read more
6 related stories
3d
Perth Now
Better margins new drugs keep GSK on trackhad forecast sales of STG6.01 billion and core EPS, which excludes certain item
Better margins new drugs keep GSK on track
Perth Now / Posted 3 days ago
had forecast sales of STG6.01 billion and core EPS, which excludes certain items, of 17.9p, according to Thomson Reuters. GSK said it expected 10 to 12 percentage growth in 2016 core EPS at constant currencies and confirmed that the dividend, one... Read more
6 related stories
3d
The Courier Mail
Better margins new drugs keep GSK on trackhad forecast sales of STG6.01 billion and core EPS, which excludes certain item
Better margins new drugs keep GSK on track
The Courier Mail / Posted 3 days ago
had forecast sales of STG6.01 billion and core EPS, which excludes certain items, of 17.9p, according to Thomson Reuters. GSK said it expected 10 to 12 percentage growth in 2016 core EPS at constant currencies and confirmed that the dividend, one... Read more
6 related stories
3d
Channel NewsAsia
Better margins and new drugs keep GlaxoSmithKline on trackforecast sales of 6.01 billion pounds and core EPS, which excludes certain item
Better margins and new drugs keep GlaxoSmithKline on track
Channel NewsAsia / Posted 3 days ago
forecast sales of 6.01 billion pounds and core EPS, which excludes certain items, of 17.9p, according to Thomson Reuters. GSK said it expected 10 to 12 percentage growth in 2016 core EPS at constant currencies and confirmed that the dividend, one... Read more
6 related stories
3d
Market Watch
GlaxoSmithKline profit falls after Novartis dealLONDON--GlaxoSmithKline PLC GSK, -0.61% said net profit fell in the first quart
GlaxoSmithKline profit falls after Novartis deal
Market Watch / Posted 3 days ago
LONDON--GlaxoSmithKline PLC GSK, -0.61% said net profit fell in the first quarter due to a tough year-earlier comparison, which was boosted by proceeds from its three-way transaction with Novartis AG; taking out that effect, profit rose--partly due... Read more
3d
CNBC
New products and vaccines a shot in the arm for GSKabout flagging sales and profits. Some such as Neil Woodford, one of the U.K.'s
New products and vaccines a shot in the arm for GSK
CNBC / Posted 3 days ago
about flagging sales and profits. Some such as Neil Woodford, one of the U.K.'s best-known fund managers, have called for GSK's consumer health division to be spun off. In the last quarter of 2015, GSK beat forecasts by a small margin, despite a... Read more
3d
Investopedia
Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)medicine to become a larger share of revenues in the future as well.GlaxoSmithK
Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)
Investopedia / Posted 3 days ago
medicine to become a larger share of revenues in the future as well.GlaxoSmithKline GlaxoSmithKline PLC (NYSE: GSK), with a market capitalization of $94 billion, is another of the world’s largest pharmaceutical and health care... Read more
4d
WA Today
Australia's human guinea pigs in demand from Asia for clinical trialswanting traditional Chinese medicines tested in a clinical setting. CMAX has c
Australia's human guinea pigs in demand from Asia for clinical trials
WA Today / Posted 4 days ago
wanting traditional Chinese medicines tested in a clinical setting. CMAX has customers including pharmaceutical giants GSK, Merck, and Pfizer along with a host of smaller drug development companies that outsource their trials as an answer to... Read more
4 related stories
4d
Brisbane Times
Australia's human guinea pigs in demand from Asia for clinical trialswanting traditional Chinese medicines tested in a clinical setting. CMAX has c
Australia's human guinea pigs in demand from Asia for clinical trials
Brisbane Times / Posted 4 days ago
wanting traditional Chinese medicines tested in a clinical setting. CMAX has customers including pharmaceutical giants GSK, Merck, and Pfizer along with a host of smaller drug development companies that outsource their trials as an answer to... Read more
4 related stories
4d
The Age
Australia's human guinea pigs in demand from Asia for clinical trialswanting traditional Chinese medicines tested in a clinical setting. CMAX has c
Australia's human guinea pigs in demand from Asia for clinical trials
The Age / Posted 4 days ago
wanting traditional Chinese medicines tested in a clinical setting. CMAX has customers including pharmaceutical giants GSK, Merck, and Pfizer along with a host of smaller drug development companies that outsource their trials as an answer to... Read more
4 related stories
4d
Sydney Morning Herald
Australia's human guinea pigs in demand from Asia for clinical trialswanting traditional Chinese medicines tested in a clinical setting. CMAX has c
Australia's human guinea pigs in demand from Asia for clinical trials
Sydney Morning Herald / Posted 4 days ago
wanting traditional Chinese medicines tested in a clinical setting. CMAX has customers including pharmaceutical giants GSK, Merck, and Pfizer along with a host of smaller drug development companies that outsource their trials as an answer to... Read more
4 related stories
4d
Canberra Times
Australia's human guinea pigs in demand from Asia for clinical trialswanting traditional Chinese medicines tested in a clinical setting. CMAX has c
Australia's human guinea pigs in demand from Asia for clinical trials
Canberra Times / Posted 4 days ago
wanting traditional Chinese medicines tested in a clinical setting. CMAX has customers including pharmaceutical giants GSK, Merck, and Pfizer along with a host of smaller drug development companies that outsource their trials as an answer to... Read more
4 related stories
4d
WA Today
How high the CPIHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
How high the CPI
WA Today / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
Canberra Times
How high the CPIHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
How high the CPI
Canberra Times / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
Brisbane Times
How high the CPIHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
How high the CPI
Brisbane Times / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
Canberra Times
ASX poised to edge higherHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
ASX poised to edge higher
Canberra Times / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
Brisbane Times
ASX poised to edge higherHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
ASX poised to edge higher
Brisbane Times / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
Sydney Morning Herald
ASX poised to edge higherHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
ASX poised to edge higher
Sydney Morning Herald / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
WA Today
ASX poised to edge higherHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
ASX poised to edge higher
WA Today / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
The Age
ASX poised to edge higherHughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoi
ASX poised to edge higher
The Age / Posted 4 days ago
Hughes, Anthem, Banco Santander (Brasil), Moelis & Co, Nintendo, Nomura, Statoil, Nordea Bank, Total, Banco Santander, GSK, Barclays, Deutsche Boerse, Home Retail Group. The US dollar fell toward a 10-month low after a report showed orders for... Read more
224 related stories
4d
National Post
Story | Business Wire News Releases | News | Financial Postantibodies and antibody drug conjugates, announced today that it has entered in
Story | Business Wire News Releases | News | Financial Post
National Post / Posted 4 days ago
antibodies and antibody drug conjugates, announced today that it has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific antibodies enabled using Zymeworks’ Azymetric™... Read more
3 related stories
4d
Business Wire
Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodiesantibodies and antibody drug conjugates, announced today that it has entered in
Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies
Business Wire / Posted 4 days ago
antibodies and antibody drug conjugates, announced today that it has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific antibodies enabled using Zymeworks’ Azymetric™... Read more
3 related stories
5d
Springfield News-Sun
Clark County Common Pleas Court casesMortgage Company to Venture Real Estate Group LLC, 612 Mavor St., Springfield;
Clark County Common Pleas Court cases
Springfield News-Sun / Posted 5 days ago
Mortgage Company to Venture Real Estate Group LLC, 612 Mavor St., Springfield; $27,800. T & A Grocery and Carry Out to GSK Land LLC, 1572 Kenton St., Springfield; $29,000. Ocwen Loan Servicing LLC to Secretary of US Department of Housing and... Read more
5d
AllAfrica.com
How Smart Partnerships Can Help Eliminate Malaria By 2030plague, and I am proud that my company is taking a leading role in finding a la
How Smart Partnerships Can Help Eliminate Malaria By 2030
AllAfrica.com / Posted 5 days ago
plague, and I am proud that my company is taking a leading role in finding a lasting solution to the epidemic. Since 2003, GSK has committed over $6.9 million to community initiatives fighting malaria and has partnered with organisations on the... Read more
2 related stories
5d
Inquirier.net
Groups demand cheaper pneumonia vaccine for Filipino kidsby NextDayBetter and Doctors Without Borders that is directed at two pharmaceut
Groups demand cheaper pneumonia vaccine for Filipino kids
Inquirier.net / Posted 5 days ago
by NextDayBetter and Doctors Without Borders that is directed at two pharmaceutical companies – Pfizer and GlaxoSmithKline (GSK) – the only two producers of the life-saving pneumonia vaccine. “We need Pfizer and GSK to lower the pneumonia vaccine... Read more
5d
North-West Evening Mail
Kirkby United back on top after Barrow Celtic wintwo points after being held to a 1-1 draw at Askam United reserves, with Warren
Kirkby United back on top after Barrow Celtic win
North-West Evening Mail / Posted 5 days ago
two points after being held to a 1-1 draw at Askam United reserves, with Warren Smithson scoring for Holker. Third-placed GSK Ulverston Rangers reserves beat Bootle 2-0 thanks to goals from Craig Bowd and Ronan Simpson. Haverigg United are fourth... Read more
6d
The Economic Times
Global disinflationary pressure will not let Fed rate hike in a hurry: SreesankarHDFC Bank, Tata Motors, HCL Technologies, L&T, Maruti Suzuki, IOC, IndusInd Ban
Global disinflationary pressure will not let Fed rate hike in a hurry: Sreesankar
The Economic Times / Posted 6 days ago
HDFC Bank, Tata Motors, HCL Technologies, L&T, Maruti Suzuki, IOC, IndusInd Bank, Aurobindo Pharma, Dabur, Britannia, ACC, GSK Consumer, Cummins, Glenmark, Petronet Energy among our top picks. Similarly in the midcap space, we like Dr Reddy's Labs,... Read more
7d
Business Standard India
Cipla bets big on consumer health segmentthe crowded segment with both local and multi-national drug companies including
Cipla bets big on consumer health segment
Business Standard India / Posted 7 days ago
the crowded segment with both local and multi-national drug companies including Sun Pharmaceuticals, Piramal Enterprises, GSK, Abbott and Pfizer competing for a pie of the business. Cipla sold its only consumer health product — oral contraceptive... Read more
9d
North-West Evening Mail
Do you know someone worthy of a Heart of Ulverston award? Nominate them here today.is served ahead of the main event. This year there are 11 categories, all supp
Do you know someone worthy of a Heart of Ulverston award? Nominate them here today.
North-West Evening Mail / Posted 9 days ago
is served ahead of the main event. This year there are 11 categories, all supported by local businesses and organisations. GSK, which has a major base in Ulverston is the headline sponsor for the event. Evening Mail editor James Higgins, who will... Read more
More

People in this news